These dogs also
produce amyloid in organs such as the kidneys affecting their function.
There are some data that suggest the pathogens themselves can
produce amyloid precursor protein (APP), which is processed into amyloid - β by the cell (2).
Those whose brains could
produce amyloid - beta showed an advantage in resisting infections.
He and his colleagues showed that nerve cells engineered to
produce amyloid - beta were better able than other cells to stand up to the infectious Candida albicans, a fungus.
The new strategy targets an enzyme that helps
produce amyloid - β.
Not exact matches
«Because brain cells release
amyloid beta during activity, we think if the brain cells can't rest the way they're supposed to and get that deep sleep, they
produce a relative excess of
amyloid,» Dr. Yo - El Ju of Washington University, an author of that study, told Reuters.
IN BRIEF Scientists have new evidence that suggests that THC inhibits the formation of
amyloid plaques by blocking the enzyme in the brain that
produces them.
The amygdala, it turns out, does not
produce much alpha secretase, and even with the help of AF267B could not make enough to block the formation of beta -
amyloid.
RIDE THE WAVES Compared with a mouse that received random brain stimulation (right), a mouse stimulated to
produce more gamma waves (left) had less
amyloid - beta (green) in its hippocampus.
That's because the boosted mice
produced normal — rather than high — levels of the
amyloid precursor proteins from which plaques are made.
The study, published in Nature Communications, shows that membralin regulates the cell's machinery for
producing beta -
amyloid (or
amyloid beta, Aβ), the protein that causes neurons to die in Alzheimer's disease.
Lu and his colleagues chose to work with the bacterium E. coli because it naturally
produces biofilms that contain so - called «curli fibers» —
amyloid proteins that help E. coli attach to surfaces.
Next, the scientists tested their hypothesis in the widely studied worm Caenorhabditis elegans, and found that a strain genetically engineered to
produce excess
amyloid in their guts survived up to 3 days longer after an exposure to Salmonella and yeast than typical worms.
It not only prevented the buildup of
amyloid beta (Aß), a sticky protein linked to Alzheimer's, but it also does not appear to
produce the dangerous side effects of earlier versions tested in humans.
First, the researchers used mice that had been genetically modified to
produce excess amounts of the human version of ß
amyloid — a common Alzheimer's disease model.
«That might allow more
amyloid beta to infiltrate the brain, supplementing what is
produced by the brain itself and accelerating the deterioration.»
For example, antibodies targeting
amyloid - β peptide (Aβ)
produce inflammation in the brain in some patients.
Besides the brain,
amyloid - beta is
produced in blood platelets, blood vessels and muscles, and its precursor protein is found in several other organs.
UBC Psychiatry Professor Dr. Weihong Song and Neurology Professor Yan - Jiang Wang at Third Military Medical University in Chongqing attached normal mice, which don't naturally develop Alzheimer's disease, to mice modified to carry a mutant human gene that
produces high levels of a protein called
amyloid - beta.
People with Type 2 diabetes have an excess of a protein called islet
amyloid polypeptide, or IAPP, and the accumulation of this protein is linked to the loss of insulin -
producing pancreatic beta cells.
Some Alzheimer's researchers have cited evidence indicating that free - floating
amyloid helps
produce the corrupted p - tau via a chain of reactions that centers around GSK3 (Glycogen synthase kinase 3), an enzyme that arms tau with phosphorous, turning it into a potential biochemical assassin.
«The body
produces a lot of
amyloids after an injury, so in some circumstances, they may be performing a guardian function,» says study co-author and Stanford neurologist Lawrence Steinman.
b - secretase acts like a pair of molecular scissors, snipping a piece off a large protein to
produce b -
amyloid, a smaller protein that builds up in plaques in the brains of Alzheimer's patients and is thought to kill neurons.
That variety cropped up in a different part of the brain than the other strains, and it also
produced clumps of proteins akin to the
amyloid plaques found in sporadic Creutzfeldt - Jakob disease, a fatal brain disease of unknown origin that usually affects those over age 55.
The cells also
produce a hormone called islet
amyloid polypeptide, or IAPP.
«Our previous work showed that compared to APOE3, the apolipoprotein
produced by the APOE4 gene does not bind well to
amyloid - beta and so does not clear the neurotoxin from the brain.»
And more direct evidence for its role in making plaques is the fact that cells
produced more beta
amyloid if they contained certain mutated forms of nicastrin, the researchers report in the 7 September issue of Nature.
Amyloid is the umbrella term for protein fragments that are
produced by the body and that ultimately lead to the demise of nerve cells.
All of this promoted the idea that
amyloid - beta plaques weren't waste products in the brain, but rather were
produced by an active immune defense system.
However, when Sup35 misfolds into its prion state, it forms
amyloid fibers similar to those found in Alzheimer's patients and causes the cell's protein -
producing machinery to go drastically awry.
By measuring the amount of labeled beta -
amyloid by mass spectroscopy over time, the researchers were able to calculate how fast it was
produced in the participants» brains and then how fast it was cleared.
If the classic approach on leeching
amyloid - beta out of the brain was
producing only colossal failure, they said, why not zero in on a key genetic trigger linked to a well - defined risk of developing the disease?
In addition,
amyloid - β,
produced by nearby neurons, may be an antimicrobial peptide that gets recruited to fight the pathogen; the peptide surrounds and seals off the pathogen (4).
They found that participants who slept very little
produced more of the protein
amyloid beta, which is linked to Alzheimer's.
The RTM hypothesis is that the immune systems of people who reach the ages at which AS, beta -
amyloid, and other pathological aggregates begin to accumulate would generate antibodies against their abnormal form, and that people who remain free of these specific diseases might be
producing antibodies that are particularly effective at keeping these aggregates at bay.
In this study, creatures that had been genetically engineered to
produce high levels of
amyloid beta were able to fight off infections from Salmonella and other microorganisms quickly and successfully.
One way the brain eliminates the
amyloid - beta typically
produced by cell activity in the brain is by moving it to the spinal fluid for disposing of.
The spiking pattern and the kind of
amyloid - beta
produced association could revolve around a protein known as presenilin.
Amyloid - beta was
produced at the same average rate by both groups, but in the Alzheimer's group there was an average drop in the clearance rates of about 30 %.
The main constituents of extracellular
amyloid plaque,
amyloid β40, 42, is
produced by the cleavage of
amyloid precursor protein (APP).»
There are other theories as to why
amyloid accumulates in the cat's pancreas, some associate it with a compound called IAPP which the pancreatic ß cells secrete in the process of
producing insulin.
While amyloidosis may present itself as a symptom of another medical condition, for those suffering from
amyloid disease, the cause will be due to issues within the actual bone marrow whereby abnormal antibodies are
produced forming
amyloid.